
Strategic Formulation & Delivery Engineering
End-to-end consulting to overcome complex bio-delivery challenges, optimize pharmacokinetics, and accelerate market timelines.
Overview
Elixis Biosciences provides end-to-end consulting to overcome complex bio-delivery challenges, optimize pharmacokinetics, and accelerate market timelines. We bridge the gap between molecular innovation and commercial scale, offering strategic formulation and delivery engineering for the biotech and pharmaceutical sectors.
​
Elixis Biosciences offers specialized consulting services to pharmaceutical developers, biotech startups, and innovative consumer wellness brands. We combine deep domain expertise in formulation chemistry with commercial foresight—helping you transform sensitive actives, poorly soluble molecules, and volatile compounds into robust, market-ready products.
Complex Formulation Development
- Lipid Nanoparticle (LNP) architecture design
- Mucoadhesive and mucosal delivery systems
- Stability and solubility optimization for BCS Class II/IV compounds
Pharmacokinetic (PK) Optimization
- Absorption, Distribution, Metabolism, and Excretion (ADME) profiling
- Controlled and sustained release kinetics
- Permeation enhancement strategies
Route-Specific Engineering
- Nasal-to-brain delivery and micro-emulsions
- Advanced transdermal patch and film technologies
- Sublingual and buccal absorption platforms
Strategic CMC & Scale-Up
- Chemistry, Manufacturing, and Controls (CMC) roadmap
- Tech transfer and process scale-up strategy
- Regulatory filing support and documentation
Core Service Offerings

1. Custom Formulation Design & Feasibility
​
-
We engineer tailored delivery systems designed to maximize bioavailability, stability, and targeted release profiles.
-
Nanocarrier Design: Tailored lipid nanoparticle (LNP) compositions and lipid self-assemblies.
-
Solubilization Strategies: Lipid-based formulations, self-emulsifying systems (SEDDS/SNEDDS), and co-solvent systems for poorly water-soluble actives.
-
Alternative Route Optimization: Transmucosal (sublingual, nasal) and transdermal matrix development to bypass first-pass metabolism.
​
2. Physicochemical Characterization & Pre-formulation
​
-
De-risk your developmental pipeline early with rigorous analytical evaluation and kinetic profiling.
-
Excipient compatibility and matrix selection.
-
Permeation testing and flux modeling (in vitro / ex vivo evaluation).
-
Particle size analysis, zeta potential evaluation, and encapsulation efficiency profiling.
-
Accelerated stability and degradation study design.
​
3. IP Strategy & Portfolio Technology Transfer
Â
-
Turn scientific breakthroughs into defensible, enterprise-level intellectual property.
-
IP Landscape Evaluation: Gap analysis, freedom-to-operate technical reviews, and patentable formulation design.
-
Technology Licensing: Seamless integration of proprietary Elixis IP (LNPs, sublingual gels, SNEDDS, transdermal systems) into your existing product pipeline.
-
Scale-Up & Tech Transfer: Translating laboratory-scale formulations into scalable, compliant manufacturing protocols (cGMP transfer support).
​
4. Consumer HealthCare  Product Development
​
-
Apply pharmaceutical-grade delivery technology to premium, high-growth consumer wellness applications.
-
Translating complex pharma delivery methods into consumer-friendly, compliant formats.
-
Ingredient stability in non-standard matrices (functional beverages, mucosal gels, topical patches).
-
Labeling, claim support, and scientific narrative development for technical marketing.
Why Partner With Elixis?
- Molecular Precision: We apply high physical and chemical rigor to every delivery challenge.
- Commercial Velocity: Engineering solutions designed for manufacturing and market entry.
- IP Generation: Developing next-generation platforms that strengthen your asset portfolio.